These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 23423974)
1. On being a neurologist in industry. Leppert D; Glanzman R Ann Neurol; 2013 Mar; 73(3):319-26. PubMed ID: 23423974 [TBL] [Abstract][Full Text] [Related]
2. Role of neurologists in the pharmaceutical industry. Peroutka SJ West J Med; 1994 Sep; 161(3):328-30. PubMed ID: 7975576 [TBL] [Abstract][Full Text] [Related]
3. [The physician in the pharmaceutical industry]. Lopes ID; Gomes MV; Branco JC Acta Med Port; 1993 Jul; 6(7):361-5. PubMed ID: 8379357 [TBL] [Abstract][Full Text] [Related]
4. The pharmaceutical industry and academic medicine: opportunities for physician collaboration. Jefferis JE Circulation; 1985 Aug; 72(2 Pt 2):I21-4. PubMed ID: 3924438 [No Abstract] [Full Text] [Related]
5. The ethics of drug development and promotion: the need for a wider view. Brody H Med Care; 2012 Nov; 50(11):910-2. PubMed ID: 23047778 [TBL] [Abstract][Full Text] [Related]
7. Translational research: the changing landscape of drug discovery. Fishburn CS Drug Discov Today; 2013 May; 18(9-10):487-94. PubMed ID: 23247258 [TBL] [Abstract][Full Text] [Related]
8. Physician-Scientist Careers in the Biotechnology and Pharmaceutical Industries. Ganem D J Infect Dis; 2018 Aug; 218(suppl_1):S20-S24. PubMed ID: 30124980 [TBL] [Abstract][Full Text] [Related]
9. [Role of neurologists on the management of stroke care unit and/or stroke unit]. Okada Y; Goto S; Jinnouchi J; Ogata T; Yasaka M Rinsho Shinkeigaku; 2006 Nov; 46(11):833-5. PubMed ID: 17432193 [TBL] [Abstract][Full Text] [Related]
10. Industrial pharmaceutical drug research has done more for the health of people with MS than academic neurologists: yes. Havrdová E Mult Scler; 2012 Sep; 18(9):1209-10. PubMed ID: 22936682 [No Abstract] [Full Text] [Related]
15. Physicians and the pharmaceutical industry (update 2001). Canadian Medical Association CMAJ; 2001 May; 164(9):1339-44. PubMed ID: 11341156 [No Abstract] [Full Text] [Related]
16. [The physician in the pharmaceutical industry]. Benkert K Fortschr Med; 1987 Aug; 105(25):480-2. PubMed ID: 3666644 [No Abstract] [Full Text] [Related]
17. The hidden costs of free lunches: fraud and abuse in physician-pharmaceutical arrangements. Gosfield AG J Med Pract Manage; 2005; 20(5):253-8. PubMed ID: 15921138 [TBL] [Abstract][Full Text] [Related]
18. Medicines and people in the Third World--the role of the industry. The Association of the Danish Pharmaceutical Industry (MEFA). Dan Med Bull; 1984 Nov; 31 Suppl 1():6-8. PubMed ID: 6518831 [No Abstract] [Full Text] [Related]
19. Portfolio management in early stage drug discovery - a traveler's guide through uncharted territory. Betz UA Drug Discov Today; 2011 Jul; 16(13-14):609-18. PubMed ID: 21600301 [TBL] [Abstract][Full Text] [Related]
20. Drug development in the light of translational science: shine or shade? Wehling M Drug Discov Today; 2011 Dec; 16(23-24):1076-83. PubMed ID: 21820527 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]